Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19
Clinical trial NCT04403880 · COMPLETED
Trial details
- NCT number
- NCT04403880
- Sponsor
- HIV Vaccine Trials Network
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-13
- Primary completion
- 2022-04-21
- Enrollment
- 760
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.